Sitagliptin‐mediated preservation of endothelial progenitor cell function via augmenting autophagy enhances ischaemic angiogenesis in diabetes

Recently, the dipeptidyl peptidase‐4 (DPP‐4) inhibitor sitagliptin, a major anti‐hyperglycaemic agent, has received substantial attention as a therapeutic target for cardiovascular diseases via enhancing the number of circulating endothelial progenitor cells (EPCs). However, the direct effects of si...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Xiaozhen, Zeng, Jun, Yan, Xiaoqing, Lin, Qian, Wang, Kai, Chen, Jing, Shen, Feixia, Gu, Xuemei, Wang, Yuehui, Chen, Jun, Pan, Kejian, Cai, Lu, Wintergerst, Kupper A., Tan, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742710/
https://www.ncbi.nlm.nih.gov/pubmed/28799229
http://dx.doi.org/10.1111/jcmm.13296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742710/
https://www.ncbi.nlm.nih.gov/pubmed/28799229
http://dx.doi.org/10.1111/jcmm.13296

Ejemplares similares